Hound Partners’s Orphazyme A/S ORPH Stock Holding History

Hound Partners’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-100,000	Closed	-$1.03M	–	149
2020 Q3	$1.03M	Buy	+100,000	New	+$1M	0.07%	86

Other funds holding ORPH

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Hound Partners's ORPH Position: Q4 2020 in Review

Hound Partners sold out of Orphazyme A/S (ORPH) in Q4 2020, closing a stake of 100,000 shares — an estimated $1.03M sold.

Hound Partners first reported a position in ORPH in Q3 2020 and held it in 1 quarter. The position peaked at $1.03M in Q3 2020. 5 funds tracked by Wall St. Rank hold ORPH as of Q4 2020.

Hound Partners reported no remaining Orphazyme A/S position as of Q4 2020 after selling out during the quarter.
Hound Partners sold 100,000 Orphazyme A/S shares in Q4 2020, an estimated $1.03M.
Hound Partners first reported a position in Orphazyme A/S in Q3 2020 and held it in 1 quarter.
Hound Partners's Orphazyme A/S position peaked at $1.03M in Q3 2020.
5 funds tracked by Wall St. Rank held Orphazyme A/S as of Q4 2020.

Based on Hound Partners's 13F filing for Q4 2020, filed 16 Feb 2021.